Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 16, 2015Journal of Nuclear Medicine

Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMartina BenešováGerman Cancer Research CenterMSMartin SchäferGerman Cancer Research CenterUBUlrike Bauder‐WüstGerman Cancer Research Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Benešová et al. (2015) studied this question.

synapsesocial.com/papers/69d791643fae90fd6048fd03https://doi.org/10.2967/jnumed.114.147413
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Influence of Different Spacers on the Biological Profile of a DOTA−Somatostatin Analogue2006 · 77 citations
  2. 2Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer2014 · 383 citations